Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.460
-0.040 (-2.67%)
Nov 6, 2026, 4:00 PM EST - Market closed

Health Catalyst Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-202.09-177.97-69.5-118.15-137.4-153.21
Depreciation & Amortization
33.23831.7333.7241.535.13
Other Amortization
14.6516.2312.9610.018.314.35
Asset Writedown & Restructuring Costs
204117.122.24.085.021.8
Loss (Gain) From Sale of Investments
-0.98-1.57-4.76-9.72-2.241.2
Stock-Based Compensation
14.6627.0140.1355.7672.165.15
Provision & Write-off of Bad Debts
1.141.51.21.820.690.5
Other Operating Activities
11.73-4.481.263.07-9.347.35
Change in Accounts Receivable
11.29-1.814.28-13.660.790.1
Change in Accounts Payable
9.19-11.515.584.87-4.75.2
Change in Unearned Revenue
-4.670.61-7.01-1.49-67.64
Change in Other Net Operating Assets
0.59-2.4-3.51-3.39-4-8.33
Operating Cash Flow
26.820.7314.56-33.08-35.27-23.12
Operating Cash Flow Growth
--94.98%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.11-0.97-1.62-1.24-2.17-10.45
Sale of Property, Plant & Equipment
0.040.040.010.030.030.02
Cash Acquisitions
--41.11-80.28-11.39-27.85-46.76
Sale (Purchase) of Intangibles
-19.82-20.59-14.78-13.08-15.25-8.02
Investment in Securities
26.8398.8273.7645.976.21-74.47
Investing Cash Flow
150.3936.19-22.920.29-39.02-139.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--152.28---
Long-Term Debt Repaid
--232.29-0.96---
Net Debt Issued (Repaid)
-164.37-232.29151.32---
Issuance of Common Stock
0.61.512.584.547.12270.37
Repurchase of Common Stock
--5--1.81-8.39-
Other Financing Activities
---2.15--1.34-6.29
Financing Cash Flow
-163.77-235.78151.752.73-2.61264.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.010.03-0.030.02-0.01-0.01
Net Cash Flow
13.44-198.83143.37-10.04-76.92101.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
25.71-0.2412.94-34.32-37.44-33.57
Free Cash Flow Growth
------
Free Cash Flow Margin
9.45%-0.08%4.22%-11.60%-13.55%-13.88%
Free Cash Flow Per Share
0.35-0.000.21-0.61-0.69-0.71
Levered Free Cash Flow
19.3510.7329.4517.8813.0424.68
Unlevered Free Cash Flow
30.2222.1736.8720.8512.5912.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
21.9521.9510.125.755.756.36
Cash Income Tax Paid
----0.30.14
Change in Working Capital
16.4-15.11-0.66-13.67-13.914.62
SEC Filings: 10-K · 10-Q